US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 24.580
  • +0.510+2.12%
Close Oct 31 16:00 ET
  • 24.580
  • 0.0000.00%
Post 20:01 ET
1.74BMarket Cap-8475P/E (TTM)

About Nurix Therapeutics Company

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.

Company Profile

SymbolNRIX
Company NameNurix Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2009
CEODr. Arthur T. Sands, M.D.,PhD
MarketNASDAQ
Employees284
Fiscal Year Ends11-30
Address1700 Owens Street,Suite 205
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-660-5320
Websitehttp://www.nurixtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Arthur T. Sands, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 4.36M
  • Hans van Houte
  • Chief Financial Officer and Principal Accounting Officer
  • 1.61M
  • Dr. Christine Ring, J.D.,PhD
  • Chief Legal Officer, Chief Compliance Officer and Secretary
  • --
  • Dr. Gwenn Hansen, PhD
  • Chief Scientific Officer
  • 1.63M
  • Dr. David L. Lacey, M.D.
  • Chairman of the Board
  • 263.29K
  • Anil Kapur
  • Director
  • --
  • Edward C. Saltzman
  • Independent Director
  • 223.29K
  • Julia P. Gregory
  • Independent Director
  • 238.29K
  • Judith A. Reinsdorf, J.D.
  • Independent Director
  • 225.79K
  • Paul M. Silva
  • Independent Director
  • 225.79K
  • Dr. Lori Anne Kunkel, M.D.
  • Independent Director
  • 228.29K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data